(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 6.57%4.27B | ---- | ---- | ---- | -30.51%4.01B | ---- | ---- | ---- | 64.90%5.76B |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | 51.41%30.11M | ---- | ---- | ---- | --19.89M | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -12.41%5.77B | ---- | ---- | ---- | 42.14%6.58B | ---- | ---- | ---- | -23.34%4.63B |
-Other impairments and provisions | ---- | -12.41%5.77B | ---- | ---- | ---- | 42.14%6.58B | ---- | ---- | ---- | -3.38%4.63B |
Revaluation surplus: | ---- | 196.24%4.53M | ---- | ---- | ---- | ---4.7M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | 196.24%4.53M | ---- | ---- | ---- | ---4.7M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.12M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.12M |
Depreciation and amortization: | ---- | -4.18%73.76M | ---- | ---- | ---- | 16.69%76.98M | ---- | ---- | ---- | 82.94%65.97M |
-Depreciation | ---- | -4.18%73.76M | ---- | ---- | ---- | --76.98M | ---- | ---- | ---- | ---- |
Exchange Loss (gain) | ---- | -101.47%-2.36M | ---- | ---- | ---- | 550.70%160.23M | ---- | ---- | ---- | 64.99%-35.55M |
Special items | ---- | -7.08%185.6M | ---- | ---- | ---- | -21.34%199.74M | ---- | ---- | ---- | -15.69%253.92M |
Operating profit before the change of operating capital | ---- | -6.47%10.33B | ---- | ---- | ---- | 3.48%11.04B | ---- | ---- | ---- | 9.18%10.67B |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 39.42%-424.55M | ---- | ---- | ---- | 45.17%-700.79M | ---- | ---- | ---- | 57.25%-1.28B |
Accounts payable increase (decrease) | ---- | 20.87%407.89M | ---- | ---- | ---- | 178.35%337.47M | ---- | ---- | ---- | -58.03%121.24M |
prepayments (increase)decrease | ---- | -48.27%247.89M | ---- | ---- | ---- | 827.98%479.17M | ---- | ---- | ---- | -80.95%51.64M |
Cash from business operations | ---- | -5.37%10.56B | ---- | ---- | ---- | 16.64%11.16B | ---- | ---- | ---- | 30.26%9.57B |
Other taxs | ---- | 173.74%167.47M | ---- | ---- | ---- | -830.03%-227.11M | ---- | ---- | ---- | 130.09%31.11M |
Interest received - operating | ---- | -335.43%-136.36M | ---- | ---- | ---- | 37.36%-31.32M | ---- | ---- | ---- | -250.59%-50M |
Special items of business | 11.20%1.96B | 30.26%-3.47B | 15.41%4.77B | 38.80%3.52B | 24.06%1.76B | -32.46%-4.98B | 243.08%4.13B | 214.34%2.54B | --1.42B | -92.92%-3.76B |
Net cash from operations | 11.20%1.96B | 20.19%7.12B | 15.41%4.77B | 38.80%3.52B | 24.06%1.76B | 2.29%5.92B | 9.31%4.13B | 26.79%2.54B | --1.42B | 8.71%5.79B |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | ---- | -52.29%-11.07B | ---- | ---- | ---- | -20.40%-7.27B | ---- | ---- | ---- | -764.90%-6.04B |
Purchase of fixed assets | ---- | -213.48%-84.55M | ---- | ---- | ---- | -6.58%-26.97M | ---- | ---- | ---- | -65.71%-25.31M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | 329.70%3.35M | ---- | ---- | ---- | ---1.46M |
Acquisition of subsidiaries | ---- | ---26.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 1,595.37%303.3M | ---- | ---- | ---- | --17.89M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | -306.77%-269.21M | ---- | ---- | ---- | ---66.18M | ---- | ---- | ---- | ---- |
Other items in the investment business | 11.95%-3.14B | ---- | -63.19%-9.26B | -159.84%-7B | -45.98%-3.56B | ---14.55M | ---5.68B | ---2.69B | ---2.44B | ---- |
Net cash from investment operations | 11.95%-3.14B | -51.55%-11.15B | -63.19%-9.26B | -159.84%-7B | -45.98%-3.56B | -21.30%-7.36B | 0.76%-5.68B | -17.76%-2.69B | ---2.44B | -779.27%-6.06B |
Net cash before financing | 34.56%-1.18B | -181.10%-4.03B | -190.86%-4.5B | -2,122.39%-3.48B | -76.42%-1.8B | -421.96%-1.43B | 20.35%-1.55B | 45.34%-156.52M | ---1.02B | -104.42%-274.63M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 148.55%897.35M | ---- | ---- | ---- | -49.05%361.03M | ---- | ---- | ---- | 279.30%708.54M |
Refund | ---- | 76.32%-176M | ---- | ---- | ---- | -31.57%-743.13M | ---- | ---- | ---- | -182.42%-564.84M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --254.92M | ---- | ---- | ---- | ---- |
Dividends paid - financing | ---- | 4.74%-941.71M | ---- | ---- | ---- | ---988.59M | ---- | ---- | ---- | ---- |
Absorb investment income | ---- | 20.20%10.41B | ---- | ---- | ---- | 37.18%8.66B | ---- | ---- | ---- | 104.17%6.31B |
Issuance expenses and redemption of securities expenses | ---- | ---636.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | 4,459.35%1.78B | -95.51%-8.49B | -34.29%1.98B | -40.11%1.28B | -96.38%38.94M | -3.52%-4.34B | 184.56%3.01B | 187.17%2.13B | --1.08B | 34.08%-4.19B |
Net cash from financing operations | 4,459.35%1.78B | -66.72%1.07B | -34.29%1.98B | -40.11%1.28B | -96.38%38.94M | 41.54%3.2B | 66.61%3.01B | 57.54%2.13B | --1.08B | 168.97%2.26B |
Effect of rate | 173.69%2.1M | 152.85%9.62M | 123.04%10.49M | 333.82%5.56M | 25.58%-2.84M | -433.33%-18.19M | 273.64%4.7M | 13.63%-2.38M | ---3.82M | -252.55%-3.41M |
Net Cash | 133.76%595.5M | -267.34%-2.96B | -271.88%-2.52B | -211.70%-2.2B | -3,308.41%-1.76B | -10.98%1.77B | 1,195.28%1.46B | 85.19%1.97B | --54.99M | -32.26%1.99B |
Begining period cash | -28.09%7.56B | 20.00%10.51B | 20.00%10.51B | -88.00%10.51B | 20.00%10.51B | 29.31%8.76B | 29.31%8.76B | 1,193.12%87.6B | --8.76B | 76.60%6.77B |
Items Period | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---78.84B | ---- | ---- |
Cash at the end | -6.73%8.16B | -28.09%7.56B | -21.74%8.01B | -22.51%8.31B | -0.75%8.75B | 20.00%10.51B | 54.11%10.23B | 36.92%10.73B | --8.81B | 29.31%8.76B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | -- | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | -- | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data